BIO
Bio-Rad Laboratories, Inc. (BIO) reported revenue of $2.58B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $2.58B | +0.7% |
| FY 2024 | $2.57B | -3.9% |
| FY 2023 | $2.67B | -4.7% |
| FY 2022 | $2.80B | -4.1% |
| FY 2021 | $2.92B | +14.8% |
| FY 2020 | $2.55B | +10.1% |
| FY 2019 | $2.31B | +1.0% |
| FY 2018 | $2.29B | +6.0% |
| FY 2017 |
Bio-Rad Laboratories, Inc. (BIO) reported revenue of $2.58B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Bio-Rad Laboratories, Inc.'s revenue grew from $2.07B to $2.58B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.16B |
| +4.4% |
| FY 2016 | $2.07B | +2.4% |
| FY 2015 | $2.02B | -7.2% |
| FY 2014 | $2.18B | +2.0% |
| FY 2013 | $2.13B | +3.1% |
| FY 2012 | $2.07B | -0.2% |
| FY 2011 | $2.07B | - |